Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Poddubnyy

Showing results (11-20 of 334) with videos related to

Pageof 34
Sort By:
Drugs|March 28, 2023
Managing Psoriatic Arthritis Patients Presenting with Axial SymptomsDenis Poddubnyy
Zeitschrift Fur Rheumatologie|November 10, 2023
[Dealing with NSAID in the treatment of axial spondylarthritis]Denis Poddubnyy
Rheumatic Diseases Clinics of North America|July 18, 2025
Axial Psoriatic Arthritis: An Evolving ConceptDenis Poddubnyy
Current Opinion in Rheumatology|May 12, 2021
Twenty years of clinical trials in axial spondyloarthritis: what can we learn for the future?Joachim Sieper, Denis Poddubnyy
Expert Opinion on Drug Safety|May 11, 2011
Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisDenis Poddubnyy, Martin Rudwaleit
Expert Opinion on Biological Therapy|April 9, 2019
IL-17 inhibition in axial spondyloarthritis: current and future perspectivesMurat Torgutalp, Denis Poddubnyy
Therapeutic Advances in Musculoskeletal Disease|June 27, 2018
Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteriaFabian Proft, Denis Poddubnyy
Nature Reviews. Rheumatology|April 24, 2025
Understanding the causes of treatment failure is crucial for the management of axial spondyloarthritisDenis Poddubnyy, Xenofon Baraliakos
Current Rheumatology Reports|July 15, 2019
Current Unmet Needs in SpondyloarthritisDenis Poddubnyy, Joachim Sieper
Best Practice & Research. Clinical Rheumatology|June 8, 2019
Emerging treatment options for spondyloarthritisMurat Torgutalp, Denis Poddubnyy
Pageof 34

Showing results (11-20 of 334) with videos related to

Sort By:
Pageof 34
Drugs|March 28, 2023
Managing Psoriatic Arthritis Patients Presenting with Axial SymptomsDenis Poddubnyy
Zeitschrift Fur Rheumatologie|November 10, 2023
[Dealing with NSAID in the treatment of axial spondylarthritis]Denis Poddubnyy
Rheumatic Diseases Clinics of North America|July 18, 2025
Axial Psoriatic Arthritis: An Evolving ConceptDenis Poddubnyy
Current Opinion in Rheumatology|May 12, 2021
Twenty years of clinical trials in axial spondyloarthritis: what can we learn for the future?Joachim Sieper, Denis Poddubnyy
Expert Opinion on Drug Safety|May 11, 2011
Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisDenis Poddubnyy, Martin Rudwaleit
Expert Opinion on Biological Therapy|April 9, 2019
IL-17 inhibition in axial spondyloarthritis: current and future perspectivesMurat Torgutalp, Denis Poddubnyy
Therapeutic Advances in Musculoskeletal Disease|June 27, 2018
Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteriaFabian Proft, Denis Poddubnyy
Nature Reviews. Rheumatology|April 24, 2025
Understanding the causes of treatment failure is crucial for the management of axial spondyloarthritisDenis Poddubnyy, Xenofon Baraliakos
Current Rheumatology Reports|July 15, 2019
Current Unmet Needs in SpondyloarthritisDenis Poddubnyy, Joachim Sieper
Best Practice & Research. Clinical Rheumatology|June 8, 2019
Emerging treatment options for spondyloarthritisMurat Torgutalp, Denis Poddubnyy
Pageof 34